My watch list
my.bionity.com  
Login  

364 Current news from the ressort manufacturing

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

New Swedish Manufacturing Facility of Viragen for Multiferon(TM)

23-Jul-2004

Viragen confirmed that its Swedish manufacturing facility in Ersboda is on schedule to commence with the production of Multiferon(TM) in September. The Company has been upgrading and expanding its production capabilities as a result of a more aggressive business direction for its natural human ...

more

Greiner Bio-One - Invests EUR 500 million in USA

21-Jul-2004

Sophisticated technology is worth the money. With the invention and development of a product for the field of diagnostics, the Austrian company located in Kremsmünster has manufactured an impressive 5 billion VACUETTE® tubes for diagnostic examinations throughout the world since 1992. As of ...

more

Boehringer Ingelheim receives FDA approval for new biopharmaceutical production plant in record time

09-Jul-2004

Boehringer Ingelheim has received official approval for its new biopharmaceutical active ingredients production plant following an inspection of the plant at the Biberach (Riss) site by the US regulatory agency, the FDA (Food and Drug Administration). The approval opens up the USA, the world's ...

more

Olympus Enhances Service Systems in China for Endoscopes and Biological Microscopes

Local sales agency absorbed and 24 offices opened to create expanded customer contact network

07-Jul-2004

Olympus Corporation anticipates further expansion of the Chinese market and has moved to expand its sales of endoscopes and biological microscopes in China by absorbing its local sales agency in China and establishing Olympus (Beijing) Sales & Service Co., Ltd. in Beijing. China's growth is ...

more

Compugen Establishes Small Molecule Drug Discovery Subsidiary

06-Jul-2004

Compugen Ltd. announced the establishment of a new subsidiary, Keddem Bioscience Ltd., focused on small molecule drug discovery. The program now being transferred to the new company was initiated in 2000 as the chemistry division of Compugen. The subsidiary's offices and laboratories are located ...

more

ALTANA Pharma investment runs into triple-digit millions

Extension of the Singen production facility

05-Jul-2004

ALTANA Pharma AG remains on course for further international growth. A new building for producing active substances for use in pharmaceutical preparations has just been opened. An official ceremony to mark the extension of the Singen production facility was held last week in the presence of ...

more

Applied Biosystems Announces Major Expansion of Taqman® SNP Genotyping Assays Product Line

Nearly Two Million Assays Now Available Via the Applied Biosystems Web Site

01-Jul-2004

Applied Biosystems, an Applera Corporation business, announced a major expansion of its TaqMan® SNP Genotyping Assays for functional genomics research. The newly available assays include an inventory of more than 30,000 TaqMan® Coding SNP Genotyping Assays, for researchers studying single ...

more

BioGenes successfully DIN EN ISO 9001:2000 certified

22-Jun-2004

Berlin. The Berlin-based Biotech-Company BioGenes, one of Europe's leading suppliers in the field of immunological services and antibody development, has successfully been DIN EN ISO 9001:2000 certified. Following an audit procedure lasting several days the external certifying body TÜV Rheinland ...

more

Maxygen and Biovitrum AB sign agreement to manufacture optimized beta interferon for phase I / II clinical trials

09-Jun-2004

Stockholm and Redwood City. Maxygen, Inc.and Biovitrum AB today announced the signing of an agreement for the manufacture of Maxygen's improved interferon beta material for Phase I and Phase II clinical development. "Biovitrum is a recognized leader in the production of protein pharmaceuticals," ...

more

Bio-America Completes the Acquisition of Novocure Inc.

27-May-2004

TORONTO - Bio-America is pleased to announce that it has completed the acquisition of all of the issued and outstanding shares of a private biotechnology company, Novocure Inc., in exchange for 4.2 million shares of Bio-America, Inc. Novocure is a private company that holds the intellectual ...

more

Page 36 From 37
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE